Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 7,705-7,716 of 10,592

Other study type icon

CompletedNCT02148042

Overgeneralization of Conditioned Fear as a Pathogenic Marker of Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disorders, AnxietyOtherOver 18 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Eating disorders, Anxiety

Behavioral study icon

CompletedNCT02421315

Overlapping Neural Circuits in Pediatric OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDBehavioralFrom 5 Years to 17 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: OCD

Behavioral study icon

CompletedNCT04948307

OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Orexo AB
Condition: Addiction

Drug study icon

TerminatedNCT00506909

Oxytocin Add on Study for Stable Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: David Feifel
Condition: Schizophrenia

Drug study icon

CompletedNCT02671266

Oxytocin Administration in BDD and OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugOver 18 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: OCD

Drug study icon

CompletedNCT02546570

Oxytocin and Affect Processing in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: PTSD

Drug study icon

TerminatedNCT02979093

Oxytocin and Brain Responses in Maternal Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 40 Years

Countries: United States
Sponsor: Lane Strathearn, MBBS PhD
Condition: Addiction

Drug study icon

CompletedNCT01752712

Oxytocin and CBSST for People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

CompletedNCT03136263

Oxytocin and Cognitive Control in Adult ADHD

This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

CompletedNCT00884897

Oxytocin and Social Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AnxietyDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia, Anxiety

Behavioral study icon

CompletedNCT03610633

Oxytocin and Stress Response in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 21 Years to 40 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

CompletedNCT01568528

Oxytocin as Adjunctive Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Emory University
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.